Leptin/Melanocortin pathway hormones in obese patients after laparoscopic sleeve gastrectomy
A. Tas, M. Atabey, P. Gokcen, M.İ. Ozel, Z.K. Karagoz, K. Ugur, S. Aydin, Y. Silig Department of Nutrition and Diet, Faculty of Health Science, Sivas Cumhuriyet University, Sivas, Turkey. saydin1@hotmail.com
OBJECTIVE: The melanocortin system is an important neural system underlying the control of body weight and food intake. This system has recently received great attention as a potential target for obesity treatment. Therefore, the objective of this study was to find out the leptin-melanocortin pathway before and after Laparoscopic Sleeve Gastrectomy (LSG) in obese patients.
PATIENTS AND METHODS: The study was carried out with a total of 144 individuals in 3 groups [control, obese group before LSG and obese group after LSG (who underwent LSG one year ago)]. The amount of leptin (LEP), leptin receptor (LEPR), tropomyosin receptor kinase receptor B (TrkB), brain-derived neurotrophic factor (BDNF), pro-opiomelanocortin (POMC) and melanocortin-4 receptors (MC4R) molecules were measured by using Enzyme-Linked Immunosorbent Assays.
RESULTS: A statistically significant difference was found between the groups in terms of body mass index (BMI) values (p = 0.001). There was also statistically significant difference present between obese before LSG group and obese after LSG group regarding the levels of LEP, TrkB, BDNF and proteins (p < 0.05). A decline was determined in the LEP and BDNF levels one year follow-up after LSG.
CONCLUSIONS: The evidence suggests that the leptin melanocortin pathway strictly regulates food intake and BMI before and after LSG surgery. This pathway should be kept under control for effectively reducing food intake and body weight in the treatment of obesity.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
A. Tas, M. Atabey, P. Gokcen, M.İ. Ozel, Z.K. Karagoz, K. Ugur, S. Aydin, Y. Silig
Leptin/Melanocortin pathway hormones in obese patients after laparoscopic sleeve gastrectomy
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 5
Pages: 1484-1491
DOI: 10.26355/eurrev_202203_28212